917 related articles for article (PubMed ID: 21455239)
1. The resurgence of covalent drugs.
Singh J; Petter RC; Baillie TA; Whitty A
Nat Rev Drug Discov; 2011 Apr; 10(4):307-17. PubMed ID: 21455239
[TBL] [Abstract][Full Text] [Related]
2. Follow-on drugs: how far should chemists look?
Giordanetto F; Boström J; Tyrchan C
Drug Discov Today; 2011 Aug; 16(15-16):722-32. PubMed ID: 21658467
[TBL] [Abstract][Full Text] [Related]
3. Approaches to mitigate the risk of serious adverse reactions in covalent drug design.
Baillie TA
Expert Opin Drug Discov; 2021 Mar; 16(3):275-287. PubMed ID: 33006907
[TBL] [Abstract][Full Text] [Related]
4. Predicting toxicities of reactive metabolite-positive drug candidates.
Kalgutkar AS; Dalvie D
Annu Rev Pharmacol Toxicol; 2015; 55():35-54. PubMed ID: 25292426
[TBL] [Abstract][Full Text] [Related]
5. The importance of drug-target residence time.
Zhang R; Monsma F
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):488-96. PubMed ID: 19562645
[TBL] [Abstract][Full Text] [Related]
6. Drug discovery beyond the rule of 5 - Opportunities and challenges.
Doak BC; Kihlberg J
Expert Opin Drug Discov; 2017 Feb; 12(2):115-119. PubMed ID: 27883294
[No Abstract] [Full Text] [Related]
7. Ask the experts: computational chemistry.
Matta CF; Hutter MC
Future Med Chem; 2018 Jul; 10(13):1521-1524. PubMed ID: 29992825
[No Abstract] [Full Text] [Related]
8. Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies.
Bauer RA
Drug Discov Today; 2015 Sep; 20(9):1061-73. PubMed ID: 26002380
[TBL] [Abstract][Full Text] [Related]
9. Benchmarking in vitro covalent binding burden as a tool to assess potential toxicity caused by nonspecific covalent binding of covalent drugs.
Dahal UP; Obach RS; Gilbert AM
Chem Res Toxicol; 2013 Nov; 26(11):1739-45. PubMed ID: 24164572
[TBL] [Abstract][Full Text] [Related]
10. Drug bioactivation, covalent binding to target proteins and toxicity relevance.
Zhou S; Chan E; Duan W; Huang M; Chen YZ
Drug Metab Rev; 2005; 37(1):41-213. PubMed ID: 15747500
[TBL] [Abstract][Full Text] [Related]
11. Designing around Structural Alerts in Drug Discovery.
Kalgutkar AS
J Med Chem; 2020 Jun; 63(12):6276-6302. PubMed ID: 31497963
[TBL] [Abstract][Full Text] [Related]
12. Multi-parameter optimization: identifying high quality compounds with a balance of properties.
Segall MD
Curr Pharm Des; 2012; 18(9):1292-310. PubMed ID: 22316157
[TBL] [Abstract][Full Text] [Related]
13. Target identification of covalently binding drugs by activity-based protein profiling (ABPP).
Pichler CM; Krysiak J; Breinbauer R
Bioorg Med Chem; 2016 Aug; 24(15):3291-303. PubMed ID: 27085673
[TBL] [Abstract][Full Text] [Related]
14. Managing the challenge of chemically reactive metabolites in drug development.
Park BK; Boobis A; Clarke S; Goldring CE; Jones D; Kenna JG; Lambert C; Laverty HG; Naisbitt DJ; Nelson S; Nicoll-Griffith DA; Obach RS; Routledge P; Smith DA; Tweedie DJ; Vermeulen N; Williams DP; Wilson ID; Baillie TA
Nat Rev Drug Discov; 2011 Apr; 10(4):292-306. PubMed ID: 21455238
[TBL] [Abstract][Full Text] [Related]
15. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
Saikia S; Bordoloi M; Sarmah R
Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
[TBL] [Abstract][Full Text] [Related]
16. The significance of acid/base properties in drug discovery.
Manallack DT; Prankerd RJ; Yuriev E; Oprea TI; Chalmers DK
Chem Soc Rev; 2013 Jan; 42(2):485-96. PubMed ID: 23099561
[TBL] [Abstract][Full Text] [Related]
17. Effective Application of Metabolite Profiling in Drug Design and Discovery.
Cerny MA; Kalgutkar AS; Obach RS; Sharma R; Spracklin DK; Walker GS
J Med Chem; 2020 Jun; 63(12):6387-6406. PubMed ID: 32097005
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive assessment of ADMET risks in drug discovery.
Wang J
Curr Pharm Des; 2009; 15(19):2195-219. PubMed ID: 19601823
[TBL] [Abstract][Full Text] [Related]
19. Drug targeting by retrometabolic design: soft drugs and chemical delivery systems.
Bodor N; Buchwald P
J Recept Signal Transduct Res; 2001; 21(2-3):287-310. PubMed ID: 11757686
[No Abstract] [Full Text] [Related]
20. Drug discovery projects. Preface.
Lawton G; Witty DR
Prog Med Chem; 2011; 50():v-vi. PubMed ID: 21476319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
